BCL2L11 and acute myeloid leukemia: Studies on human acute myeloid leukemia (AML) cells have also suggested that Obatoclax mediates the release of Bim and Bak from Mcl-1, resulting in release of cytochrome-c and apoptosis of AML cells [23].